Use of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

e11101 Background: Trastuzumab, a recombinant monoclonal antibody against HER2, has clinical activity in advanced breast cancer that over expresses HER2. We investigated its efficacy and safety aft...